Developing 212Pb Based RICs as Powerful Targeted Therapies

January 31, 2013

Developing 212Pb Based RICs as Powerful Targeted Therapies

EMIT Targeted Radiotherapy Conference

January 2013

Julien Torgue, Scientific Director, AREVA Med

Ruby Meredith, Professor, University of Alabama

Abstract

  • Developing an integrated model for RIT
  • Phase I clinical trial design overview and initial results

http://targeted-radiotherapy.com/agenda/day-one

Contact

For more information about AREVA Med, please contact:
Alison Tise
Tel.: + 1 (301) 841-1673